Advancing Next-Generation Therapeutics, Market Access & Reimbursement
2nd Annual
24 - 25 March, 2027
Copenhagen, Denmark
view program
Discover the highlights of the event
connect with us
Get your questions answered by our team
become a partner
Join as a sponsor and reserve your booth
Meet Our Featured Speakers
WHERE EUROPE DECIDES HOW THE NEXT WAVE OF OBESITY THERAPIES REACHES PATIENTS
Welcome to Obesity Therapies Europe 2027, where pharmaceutical companies, statutory insurers, HTA bodies, digital health providers, and commercial teams align to shape the future of obesity therapy across Europe.
Europe’s obesity therapy market is evolving faster than payers can adapt, with oral treatments, triple agonists, and multi-indication therapies advancing despite fragmented national reimbursement frameworks. Commercial teams are answering with pricing models for new therapeutic formats, real-world evidence for HTA, and access strategies tailored to each payer.
Join us to gain practical insights, strengthen your market access strategy, and help build a more responsive obesity therapy landscape across Europe.
Key topics for 2027
Sustaining durable, muscle-sparing weight loss over time
Examine dose de-escalation, maintenance dosing, and muscle and bone preservation strategies that counter, regain, and redefine what durable weight loss means.
Pricing next-generation oral and injectable obesity therapeutics
Compare orforglipron and oral Wegovy against manufacturing economics and pricing models for small molecule versus peptide therapies.
Responding to biosimilar entry and the first GLP-1 patent cliff
Explore how biosimilar entrants and the first obesity patent expiries reshape pricing, tendering, and commercial defence across European markets.
Expanding indications beyond weight loss through amylin and triple agonists
Assess how amylin agonists and triple agonists are expanding obesity therapy into new indications beyond primary weight loss.
Aligning with Europe's divergent HTA pathways and JCA requirements
Address divergent European reimbursement pathways and prepare for Joint Clinical Assessment requirements ahead of obesity therapy launches.
Converting out-of-pocket demand into reimbursed patient access
Learn how to convert out-of-pocket demand into reimbursed access by working across retail pharmacy, digital health, and payer channels.
INDUSTRY TOPICS
NETWORKING EVENTS
LEADING EXPERTS
Q&A SESSIONS
Latest News
they've attended our events
Engaging event with clear, direct talks and plenty of opportunity to network and exchange ideas.
Danielle Cunha
Fiocruz
A great conference bringing together startups, biotech companies, and CDMOs in one room.
Markus von Minden
EY-Parthenon
An insightful conference covering key topics in a compact, focused format.
Ananya Ray Soni
Novo Nordisk
A valuable introduction to the latest developments in drug delivery systems
Kavneet Pujji
Kindeva Drug Delivery
I valued the diversity of attendees, bringing perspectives from across different sectors.
Shabnam Mohandessi
Corden Pharma
The format is ideal for focused, meaningful interactions.
Fabrice Gritti
Waters Corporation
our sponsors
